Vera Therapeutics (VERA) Interest Coverage Ratio (2020 - 2026)
Vera Therapeutics posted quarterly Interest Coverage Ratio of 68.64 for Q1 2026, down 115.06% year-on-year from 455.64 in Q1 2025, and down 38.73% on a QoQ basis from 49.48 in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Interest Coverage Ratio data on file, last reported at 68.64 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 115.06% year-over-year to 68.64; the trailing twelve-month figure through Mar 2026 stood at 50.71 (down 556.31% YoY), and the FY2025 full-year result was 41.89, down 899.82% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 68.64, down from 49.48 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 64.47 in Q4 2022 and bottomed at 171.73 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 31.92 (2025), against an average of 38.3.
- The widest annual swing landed in 2022, when Interest Coverage Ratio jumped 107.77%; it then tumbled 207.26% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 64.47 in 2022, then dropped by 19.47% to 51.92 in 2023, then dropped by 11.15% to 46.13 in 2024, then sank by 207.26% to 49.48 in 2025, then slumped by 38.73% to 68.64 in 2026.
- The last three Interest Coverage Ratio figures came in at 68.64 (Q1 2026), 49.48 (Q4 2025), and 42.82 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -68.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.64 |
| Dec 31, 2025 | -49.48 |
| Sep 30, 2025 | -42.82 |
| Jun 30, 2025 | -42.76 |
| Mar 31, 2025 | -31.92 |
| Dec 31, 2024 | 46.13 |
| Sep 30, 2024 | -25.72 |
| Jun 30, 2024 | -19.53 |
| Mar 31, 2024 | -16.32 |
| Dec 31, 2023 | 51.92 |
| Sep 30, 2023 | -23.07 |
| Jun 30, 2023 | -24.04 |
| Mar 31, 2023 | -35.76 |
| Dec 31, 2022 | 64.47 |
| Sep 30, 2022 | -171.73 |
| Jun 30, 2022 | -117.63 |
| Mar 31, 2022 | -144.25 |
| Dec 31, 2021 | -829.25 |
| Dec 31, 2020 | -2,837.33 |
| Sep 30, 2020 | -63.08 |
| Jun 30, 2020 | -50.37 |
| Mar 31, 2020 | -102.96 |